U. Räth

1.8k total citations
41 papers, 1.3k citations indexed

About

U. Räth is a scholar working on Epidemiology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, U. Räth has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in U. Räth's work include Neuroendocrine Tumor Research Advances (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Testicular diseases and treatments (5 papers). U. Räth is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Testicular diseases and treatments (5 papers). U. Räth collaborates with scholars based in Germany, France and Belarus. U. Räth's co-authors include O Kronbörg, Attilio Giacosa, Jean Faivre, Claire Bonithon‐Kopp, Bertram Wiedenmann, David Cunningham, Peter Harper, Eric Van Cutsem, G. Pérez-Manga and C. Svensson and has published in prestigious journals such as The Lancet, Blood and Hepatology.

In The Last Decade

U. Räth

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Räth Germany 18 681 277 233 222 209 41 1.3k
Nuri Faruk Aykan Türkiye 17 564 0.8× 258 0.9× 207 0.9× 308 1.4× 147 0.7× 51 1.0k
Michael G. Alexandrakis Greece 29 767 1.1× 231 0.8× 284 1.2× 498 2.2× 223 1.1× 104 2.3k
Vassiliki L. Tsikitis United States 23 743 1.1× 534 1.9× 266 1.1× 255 1.1× 191 0.9× 92 1.6k
Yuki Kojima Japan 17 379 0.6× 177 0.6× 215 0.9× 149 0.7× 107 0.5× 104 983
Massimo Iacobelli United States 19 272 0.4× 224 0.8× 136 0.6× 102 0.5× 64 0.3× 54 1.9k
Panagiotis Samaras Switzerland 23 655 1.0× 280 1.0× 389 1.7× 312 1.4× 294 1.4× 71 1.9k
Frank S. Fan Taiwan 20 358 0.5× 366 1.3× 298 1.3× 224 1.0× 198 0.9× 84 1.4k
I Hudson United Kingdom 19 697 1.0× 563 2.0× 167 0.7× 163 0.7× 99 0.5× 28 1.8k
K Sawada Japan 25 364 0.5× 124 0.4× 224 1.0× 227 1.0× 174 0.8× 60 2.4k
Megumu Fujihara Japan 17 204 0.3× 230 0.8× 285 1.2× 155 0.7× 175 0.8× 60 990

Countries citing papers authored by U. Räth

Since Specialization
Citations

This map shows the geographic impact of U. Räth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Räth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Räth more than expected).

Fields of papers citing papers by U. Räth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Räth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Räth. The network helps show where U. Räth may publish in the future.

Co-authorship network of co-authors of U. Räth

This figure shows the co-authorship network connecting the top 25 collaborators of U. Räth. A scholar is included among the top collaborators of U. Räth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Räth. U. Räth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Räth, U., Sabrina Krautbauer, Stephan Schmid, et al.. (2024). Calprotectin, a Promising Serological Biomarker for the Early Diagnosis of Superinfections with Multidrug-Resistant Bacteria in Patients with COVID-19. International Journal of Molecular Sciences. 25(17). 9294–9294. 1 indexed citations
2.
Räth, U., et al.. (2024). Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity. Biomedicines. 12(1). 125–125. 5 indexed citations
3.
Tandon, Ravi, et al.. (2012). Lipid peroxidation and thymidine phosphorylase expression in prostate carcinoma. Journal of stress physiology & biochemistry. 8(3). 113–119.
4.
Blind, E., Friedhelm Raue, Thomas R. Meinel, et al.. (2008). Diagnostische Bedeutung von Parathormone-related-Protein bei Tumorpatienten mit Hypercalcämie. DMW - Deutsche Medizinische Wochenschrift. 118(10). 330–335. 2 indexed citations
5.
Bonithon‐Kopp, Claire, O Kronbörg, Attilio Giacosa, U. Räth, & Jean Faivre. (2000). Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. The Lancet. 356(9238). 1300–1306. 317 indexed citations
6.
Faiss, Siegbert, U. Räth, Ulrich Mansmann, et al.. (1999). Ultra-High-Dose Lanreotide Treatment in Patients with Metastatic Neuroendocrine Gastroenteropancreatic Tumors. Digestion. 60(5). 469–476. 93 indexed citations
7.
Faivre, J, et al.. (1997). Chemoprevention of metachronous adenomas of the large bowel: design and interim results of a randomized trial of calcium and fibre. ECP Colon Group.. PubMed. 6(2). 132–8. 24 indexed citations
8.
Cunningham, David, John Zalcberg, U. Räth, et al.. (1996). Final results of a randomised trial comparing ‘Tomudex’® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Annals of Oncology. 7(9). 961–965. 161 indexed citations
9.
Rudi, Jochen, Martín Müller, A. von Herbay, et al.. (1995). Lack of Association ofHelicobacter pyloriSeroprevalence and Gastric Cancer in a Population with Low Gastric Cancer Incidence. Scandinavian Journal of Gastroenterology. 30(10). 958–963. 35 indexed citations
10.
Räth, U., B.K. Upadhyaya, Hannes Böckmann, et al.. (1993). Role of Ondansetron plus Dexamethasone in Fractionated Chemotherapy. Oncology. 50(3). 168–172. 23 indexed citations
11.
Bokemeyer, Carsten, Hans‐Joachim Schmoll, Bernd Metzner, et al.. (1993). Comparison of 5 vs 10 μg/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer. Annals of Hematology. 67(2). 75–79. 7 indexed citations
12.
Bokemeyer, C., Hans‐Joachim Schmoll, A. Harstrick, et al.. (1993). A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours. European Journal of Cancer. 29(16). 2225–2231. 21 indexed citations
13.
Dörr, U., et al.. (1993). Somatostatin-Rezeptor-Szintigraphie. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 158(1). 67–73. 3 indexed citations
14.
Zuna, I., Adolf Lorenz, Heide Zerban, et al.. (1991). Computerized ultrasound B‐scan texture analysis of experimental diffuse parenchymal liver disease: Correlation with histopathology and tissue composition. Journal of Clinical Ultrasound. 19(4). 193–201. 44 indexed citations
15.
Räth, U., M Kaufmann, Bertram Wiedenmann, et al.. (1991). Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites. European Journal of Cancer and Clinical Oncology. 27(2). 121–125. 53 indexed citations
16.
Harstrick, A., Hans‐Joachim Schmoll, Carsten Bokemeyer, et al.. (1991). Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma. Journal of Cancer Research and Clinical Oncology. 117(S4). S198–S202. 3 indexed citations
17.
Räth, U., Hans‐Henning Flechtner, C. Manegold, et al.. (1990). Etoposide, Adriamycin, and Cisplatinum (EAP) Combination Chemotherapy for Advanced Gastric Cancer. Oncology Research and Treatment. 13(3). 194–197. 7 indexed citations
18.
Männel, D, Andreas M. Kist, U. Räth, et al.. (1989). Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor. British Journal of Cancer. 60(4). 585–588. 10 indexed citations
19.
Hohenberger, Peter, P. Schlag, R. Herrmann, & U. Räth. (1989). Intrahepatic 5-FU Retreatment of Liver Metastases of Colorectal Cancer That Were Progressive Under Previous Systemic Chemotherapy. American Journal of Clinical Oncology. 12(5). 447–452. 4 indexed citations
20.
Wiedenmann, Bertram, et al.. (1988). Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201–995. Journal of Molecular Medicine. 66(2). 75–77. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuri Faruk Aykan Breakdown of academic impact, for papers by Michael G. Alexandrakis Breakdown of academic impact, for papers by Vassiliki L. Tsikitis Breakdown of academic impact, for papers by Yuki Kojima Breakdown of academic impact, for papers by Massimo Iacobelli Breakdown of academic impact, for papers by Panagiotis Samaras Breakdown of academic impact, for papers by Frank S. Fan Breakdown of academic impact, for papers by I Hudson Breakdown of academic impact, for papers by K Sawada Breakdown of academic impact, for papers by Megumu Fujihara
Rankless by CCL
2026